Aug 15, 2017 - Gilead Sciences' CEO hints that buying a biotech with an oncology focus might not happen. Here's what this could mean for the big biotech.
Aug 14, 2017 - It's been a pretty good year for biotech, but these three stocks have tumbled. Is the pessimism overblown?
Aug 13, 2017 - Big biotech deals have been few and far between so far in 2017. But just wait till next year.
Aug 01, 2017 - Incyte Corp. (NASDAQ:INCY)Q2 2017 Earnings CallAugust 01, 2017 10:00 am ETExecutivesMichael Charles A. Booth - Incyte Corp.Hervé Hoppenot - Incyte Corp.Barry P. Flannelly - Incyte Corp.Steven H. Stein
Jul 21, 2017 - Which is the better growth stock going forward -- Exelixis or Incyte? It depends.
Jul 21, 2017 - Calthera Biosciences, Aurinia Pharmaceuticals, and Esperion Therapeutics are some of the hottest biotech stocks in 2017, and catalysts that are on deck could suggest there's more upside ahead.
Jul 15, 2017 - You don't need a million bucks to have a winning portfolio.
Jul 02, 2017 - Is Agenus or Kite Pharma the better oncology stock to own right now?
Jun 29, 2017 - Aduro Biotech, Inc. (ADRO) has announced initiation of a phase II study to evaluate a combination therapy of its lead candidate, CRS-207, in combination with Keytruda, for treatment of patients with pleural mesothelioma (MPM).
Jun 19, 2017 - Roche Holdings has decided to walk away from co-developing NewLink Genetics IDO-inhibitor, GDC-0919.